Skip to main navigation
Skip to search
Skip to main content
Pure University (For Demo Only) Home
Help & FAQ
English
中文
Home
Profiles
Research units
Research output
Equipment
Datasets
Activities
Prizes
Impacts
Projects
Press/Media
Search by expertise, name or affiliation
Quality of vitamin k antagonist control and 1-year outcomes in patients with atrial fibrillation: A global perspective from the GARFIELD-AF registry
GARFIELD-AF Investigators
Nursing
Research output
:
Contribution to journal
›
Article
›
peer-review
134
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Quality of vitamin k antagonist control and 1-year outcomes in patients with atrial fibrillation: A global perspective from the GARFIELD-AF registry'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Adverse Outcome
16%
All Cause Mortality
66%
Anticoagulation
16%
Apoplexy
100%
Atrial Fibrillation
100%
Ciclonicate
16%
Major Bleeding
66%
Patient Care
16%
Vitamin K Antagonist
83%
Nursing and Health Professions
Adverse Outcome
16%
All Cause Mortality
66%
Anticoagulation
16%
Antivitamin K
83%
Atrial Fibrillation
100%
Bleeding
66%
Ciclonicate
16%
Clinical Practice
16%
International Normalized Ratio
33%
Patient Care
16%
Practice Guideline
16%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Outcome
16%
All Cause Mortality
66%
Antivitamin K
83%
Atrial Fibrillation
100%
Bleeding
66%
Ciclonicate
16%
Biochemistry, Genetics and Molecular Biology
All Cause Mortality
66%
Anticoagulation
16%
Atrial Fibrillation
100%
Vitamin K
83%
Neuroscience
Vitamin K Antagonist
83%
Keyphrases
Population Attributable Fraction
14%